3-Cloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a rat thyroid gland carcinogen, does not affect serum levels of TSH and thyroid hormones

Environmental Toxicology and Pharmacology

Volumn 8, Issue 4, 2000, Pages 267-273

  Komulainen, Hannu ^a   Tuominen, Raimo K ^b   Kosma, Veli Matti ^c   Huuskonen, Hannele ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Dept Pharm POB 56 F ^*  (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Chlorination; Drinking water; Furanone; Growth hormone; MX; Prolactin; Rat; Thyroxine; Triiodothyronine; TSH

Indexed keywords

3 CHLORO 4 DICHLOROMETHYL 5 HYDROXY 2(5H) FURANONE; CARCINOGEN; CYCLINE; GROWTH HORMONE; LIOTHYRONINE; PROLACTIN; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER RISK; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GROWTH HORMONE BLOOD LEVEL; HISTOPATHOLOGY; HORMONAL REGULATION; LIOTHYRONINE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RAT; SEX DIFFERENCE; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID HORMONE RELEASE; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROXINE BLOOD LEVEL;

EID: 0033800603     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(00)00052-1     Document Type: Article

References (28)

1. Barter R.A., Klaassen C.D. Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats. Toxicol. Appl. Pharmacol. 128:1994;9-17.
2. Biegel L.B., Cook J.C., O'Connor J.C., Aschiero M., Arduengo A.J. III, Slone T.W. Subchronic toxicity study in rats with 1-methyl-3-propylimidazole-2-thione (PTI): effects on the thyroid. Fundam. Appl. Toxicol. 27:1995;185-194.
3. Döhler K.-D., Wong C.C., von zur Mühlen A. The rat as model for the study of drug effects on thyroid function: consideration of methodological problems. Pharmacol. Ther. 5:1979;305-318.
4. Erwin R.A., Kirken R.A., Malabarba M.G., Farrar W.L., Rui H. Prolactin activates ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. Endocrinology. 136:1995;3512-3518.
5. Fujimoto N., Onodera H., Mitsumori K., Tamura T., Maruyama S., Ito A. Changes in thyroid function during development of thyroid hyperplasia induced by kojic acid in F344 rats. Carcinogenesis. 20:1999;1567-1571.
6. Heiskanen K., Lindström-Seppä P., Haataja L., Vaittinen S., Vartiainen T., Komulainen H. Altered enzyme activities of xenobiotic biotransformation in kidneys after subchronic administration of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) to rats. Toxicology. 100:1995;121-128.
7. Hill R.N., Erdreich L.S., Paynter O.E., Roberts P.A., Rosenthal S.L., Wilkinson C.F. Review. Thyroid follicular cell carcinogenesis. Fundam. Appl. Toxicol. 12:1989;629-697.
8. Hotz K.J., Wilson A.G.E., Thake D.C., Roloff M.V., Capen C.C., Kronenberg J.M., Brewster D.W. Mechanism of thiazopyr-induced effects on thyroid hormone homeostasis in male Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 142:1997;133-142.
9. Komulainen H., Vaittinen S.-L., Vartiainen T., Lötjönen S., Paronen P., Tuomisto J. Pharmacokinetics in rat of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a drinking water mutagen, after a single dose. Pharmacol. Toxicol. 70:1992;424-428.
10. Komulainen H., Huuskonen H., Kosma V., Lötjönen S., Vartiainen T. Toxic effects and excretion in urine of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) in the rat after a single oral dose. Arch. Toxicol. 68:1994;398-400.
11. Komulainen H., Kosma V., Vaittinen S.-L., Vartiainen T., Kaliste-Korhonen E., Lötjönen S., Tuominen R.K., Tuomisto J. Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone in the rat. J. Natl. Cancer Inst. 89:1997;848-856.
12. Kronberg L., Vartiainen T. Ames mutagenicity and concentration of the strong mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone and of its geometric isomer E-2-chloro-3-(dichloromethyl)-4-oxo-butenoic acid in chlorine-treated tap waters. Mutat. Res. 206:1988;177-182.
13. McClain R.M., Levin A.A., Posch R., Downing J.C. The effect of phenobarbital on the metabolism and excretion of thyroxine in rats. Toxicol. Appl. Pharmacol. 99:1989;216-228.
14. McClain R.M. Mechanistic considerations for the relevance of animal data on thyroid neoplasia to human risk assessment. Mutat. Res. 333:1995;131-142.
15. McConnell E.E. Thyroid follicular cell carcinogenesis: results from 343 2-year carcinogenicity studies conducted by the NCI/NTP. Regul. Toxicol. Pharmacol. 16:1992;177-188.
16. McKenzie J.M. The bioassay of thyrotropin in serum. Endocrinology. 63:1958;372-382.
17. Meier J.R., Knohl R.B., Coleman W.E., Ringhand H.P., Munch J.W., Kaylor W.H. Studies on the potent bacterial mutagen, 3-chloro-4-(dichloromethyl)-5-hydroxy- 2(5H)-furanone: aqueous stability, XAD recovery and analytical determination in drinking water and in chlorinated humic acid solutions. Mutat. Res. 189:1987;363-373.
18. Mershon J., Sall W., Mitchner N., Ben-Jonathan N. Prolactin is a local growth factor in rat mammary tumors. Endocrinology. 136:1995;3619-3623.
19. Padmapriya A.A., Just G., Lewis N.G. Synthesis of 3-chloro-4-(dichloromethyl)- 5-hydroxy-2(5H)furanone, a potent mutagen. Can. J. Chem. 63:1985;828-832.
20. Paynter O.E., Burin G.J., Jaeger R.B., Gregorio C.A. Goitrogens and thyroid follicular cell neoplasia: evidence for a threshold process. Regul. Toxicol. Pharmacol. 8:1988;102-119.
21. Sewall C.H., Flagler N., Vanden Heuvel J.P., Clark G.C., Tritscher A.M., Maronpot R.M., Lucier G.W. Alterations in thyroid function in female Sprague-Dawley rats following chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 132:1995;237-244.
22. Stevens J.T., Breckenridge C.B., Wetzel L.T., Gillis J.H., Luempert L.G. III, Eldridge J.C. Hypothesis for mammary tumorigenesis in Sprague-Dawley rats exposed to certain triazine herbicides. J. Toxicol. Environ. Health. 43:1994;139-153.
23. Takegawa K., Mitsumori K., Onodera H., Mutai M., Kitaura K., Takahashi M., Uneyama C., Yasuhara K., Takahashi M., Yanai T., Masegi T., Hayashi Y. UDP-GT involvement in the enhancement of cell proliferation in thyroid follicular cell proliferative lesions in rats treated with thiourea and vitamin A. Arch. Toxicol. 71:1997;661-667.
24. Tamura T., Mitsumori K., Onodera H., Fujimoto N., Yasuhara K., Takegawa K., Takahashi M. Inhibition of thyroid iodine uptake and organification in rats treated with kojic acid. Toxicol. Sci. 47:1999;170-175.
25. Thomas G.A., Williams E.D. Evidence for and possible mechanisms of non-genotoxic carcinogenesis in the rodent thyroid. Mutat. Res. 248:1991;357-370.
26. Thomas, G.A., Williams, E.D., 1999. Thyroid stimulating hormone (TSH)-associated follicular hypertrophy and hyperplasia as a mechanism of thyroid carcinogenesis in mice and rats. In: Capen, C.C., Dybing, E., Rice, J.M., Wilbourn, J.D. (Eds.), Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis. IARC Scientific Publications No. 147. International Agency for Research on Cancer, Lyon, pp. 45-59.
27. Vaittinen S.-L., Komulainen H., Kosma V., Julkunen A., Mäki-Paakkanen J., Jansson K., Vartiainen T., Tuomisto J. Subchronic toxicity of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) in Wistar rats. Food. Chem. Toxicol. 33:1995;1027-1037.
28. Woodman D.D. Laboratory animal endocrinology. Hormonal action, control mechanisms and interactions with drugs. 1997;John Wiley and Sons, West Sussex.